Variable | n | % |
---|---|---|
No. of Patients | 16 | Â |
Treatment Sessions | 18 | Â |
No. of Lesions | 40 | Â |
F/U from RT (months) | ||
 Median (range) | 13.2 (0.1–55.5) |  |
F/U from Brain Metastases Diagnosis (months) | ||
 Median (range) | 68.6 (16.5–249) |  |
Age at time of RT | ||
 Median (range) | 56 (40–85) |  |
KPS | ||
 100 | 2 | 13% |
 90 | 10 | 63% |
 80 | 4 | 25% |
Lesions Treated Per Patient | ||
 Median (range) | 2 (1–6) |  |
Receptors | ||
 HR+/HER2+ | 10 | 63% |
 HR−/HER2+ | 6 | 38% |
Concurrent Therapy with SRS | ||
 None | 9 | 50% |
 Chemotherapy | 1 | 5% |
 TP | 2 | 11% |
 Chemotherapy + TP | 2 | 11% |
 ET | 2 | 11% |
 ET + TKI + TP | 1 | 5% |
 ET + TP | 1 | 5% |